Latest Articles

Publication Date
Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness - Oncodaily

Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness Oncodaily

Published: Oct. 18, 2025, 9:25 p.m.
HSE boss Bernard Gloster says new endometriosis plan will improve access to surgical care - The Irish Times

HSE boss Bernard Gloster says new endometriosis plan will improve access to surgical care The Irish Times

Published: Oct. 18, 2025, 5:12 p.m.
New endometriosis framework will provide ‘faster clinical pathway’ for sufferers, says Minister for Health - The Irish Independent

New endometriosis framework will provide ‘faster clinical pathway’ for sufferers, says Minister for Health The Irish Independent

Published: Oct. 18, 2025, 3:02 p.m.
Endometriosis framework launched 18 months late but promises major improvements in women’s care - Irish Examiner

Endometriosis framework launched 18 months late but promises major improvements in women’s care Irish Examiner

Published: Oct. 18, 2025, 3 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Lelezard

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Lelezard

Published: Oct. 18, 2025, 12:47 p.m.
Dylan Sprouse reveals wife Barbara Palvin walked 2025 Victoria’s Secret Fashion Show on broken foot months after endometriosis surgery - AOL.com

Dylan Sprouse reveals wife Barbara Palvin walked 2025 Victoria’s Secret Fashion Show on broken foot months after endometriosis surgery AOL.com

Published: Oct. 18, 2025, 11:13 a.m.
Dylan Sprouse Supports Wife Barbara Palvins Health Condition By Wearing Yellow Ribbon Pin At Victorias - Free Press Journal

Dylan Sprouse Supports Wife Barbara Palvins Health Condition By Wearing Yellow Ribbon Pin At Victorias Free Press Journal

Published: Oct. 18, 2025, 11 a.m.
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - The AI Journal

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen The AI Journal

Published: Oct. 18, 2025, 10:28 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - The AI Journal

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer The AI Journal

Published: Oct. 18, 2025, 10:20 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - GlobeNewswire

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer GlobeNewswire

Published: Oct. 18, 2025, 10 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!